Ep 68 - What's next in Diabetes? CeQur moving toward manufacturing, Medtronic readying for the long haul cover art

Ep 68 - What's next in Diabetes? CeQur moving toward manufacturing, Medtronic readying for the long haul

Ep 68 - What's next in Diabetes? CeQur moving toward manufacturing, Medtronic readying for the long haul

Listen for free

View show details

About this listen

 This week's episode focuses on new hope for people with diabetes. Brad Paddock, CEO of CeQur, explains how its "wearable pen" can deliver insulin in a better way while Sean Salmon, head of Medtronic's diabetes business, reviews that company's growing portfolio. He also gives insights on its intriguing partnership with the private equity group, Blackstone. Chris Newmarker, executive editor of life sciences, drops a weighty Newmarker's Newmakers featuring stories from Hillrom, Baxter, NeuroMetrix, Philips, Medtronic and BD. Subscribe to this podcast on all major podcast apps.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.